67.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Hologic Inc Borsa (HOLX) Ultime notizie
Hologic Inc. stock outperforms competitors on strong trading day - MarketWatch
What's Behind Hologic's Positive Long-Term Outlook For Cytology Unit? - Barchart.com
Here's Why Hologic (HOLX) is a Strong Value Stock - Yahoo Finance
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit? - Nasdaq
Stock Analysis | Hologic OutlookMixed Signals Amid Strong Fundamentals and Divergent Analyst Views - AInvest
Hologic Inc. Approaches Support With Recovery in Sight2025 Key Highlights & Reliable Trade Execution Plans - classian.co.kr
Argus Upgrades Hologic to Buy From Hold, Price Target is $80 - MarketScreener
Will Hologic Inc. benefit from current market trendsPortfolio Risk Summary & AI Powered Market Entry Strategies - sundaytimes.kr
What to Expect From Hologic's Q3 2025 Earnings Report - MSN
Does Hologic Inc. have high return on assets2025 Short Interest & Weekly High Potential Stock Alerts - classian.co.kr
Saliva-based Screening Market CAGR 7.70% Trends with Thermo - openPR.com
Hologic Reports Strong Q3 2025 Earnings, Exceeds Guidance - MSN
Stephens Adjusts Price Target on Hologic to $78 From $70 - MarketScreener
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? - Yahoo Finance
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength - MSN
Hologic Management to Meet Virtually with BTIG on August 21 - AInvest
Hologic's Growth Prospects and Undervalued Stock Support Buy Rating - AInvest
Hologic Stock Performance: Underperforms Market Despite Quarterly GainsNews and Statistics - IndexBox
What Are Wall Street Analysts' Target Price for Hologic Stock? - Yahoo Finance
Hologic Stock Target Price: A Closer Look - AInvest
What Are Wall Street Analysts' Target Price For Hologic Stock? - Barchart.com
Body Fat Measurement Market to Witness Growth and Comprehensive - openPR.com
Hologic’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
HOLX Q2 Deep Dive: Breast Health Turnaround and New Product Launches Drive Momentum - FinancialContent
STD Diagnostic Market Forecast and Company Analysis Report - GlobeNewswire
STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories - Yahoo Finance
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It? - MSN
Hologic's Diagnostics Arm Set For Long-Term Upside: What's Behind It? - Barchart.com
There May Be Some Bright Spots In Hologic's (NASDAQ:HOLX) Earnings - Yahoo Finance
RadNet hires Hologic, Bausch + Lomb alum Jane Mazur - Medical Marketing and Media
Hologic’s Growth Story Looks Set For A Comeback - Finimize
RBC Capital Reiterates Buy Rating for Hologic with $87 Price Target - AInvest
RBC Capital Upgrades Hologic (HOLX) to Outperform with Raised Pr - GuruFocus
Forecasting the Future: Next-Generation Biopsy-Based Cancer - openPR.com
Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings? - The Globe and Mail
Should You Buy, Sell Or Hold Hologic Stock Post Q3 Earnings? - Barchart.com
Hpv And Pap Testing Market Generated Opportunities, Future - openPR.com
RBC Capital Upgrades Hologic to Outperform From Sector Perform, Adjusts PT to $87 From $72 - MarketScreener
RBC Capital upgrades Hologic stock to Outperform on expected growth By Investing.com - Investing.com Canada
RBC Capital upgrades Hologic stock to Outperform on expected growth - Investing.com
Molecular Diagnostics Market Expands with Infectious Disease - openPR.com
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
Analysts Have Made A Financial Statement On Hologic, Inc.'s (NASDAQ:HOLX) Third-Quarter Report - simplywall.st
Why Hologic (HOLX) is a Top Value Stock for the Long-Term - Yahoo Finance
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):